EIKN
Eikon Therapeutics, Inc. Common Stock
NASDAQ: EIKN · HEALTHCARE · BIOTECHNOLOGY
$9.62
+5.54% today
Updated 2026-04-30
Market cap
$522.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.18
Dividend yield
—
52W range
$9 – $17
Volume
0.4M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$25.60
+166.25%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy0 Buy0 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-41.79M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-242.00M | $-243.81M | $-324.25M | $-79.66M |
| EPS | — | — | — | $-6.18 |
| Free cash flow | $-219.36M | $-219.60M | $-235.26M | $-41.79M |
| Profit margin | — | — | — | — |
Peer comparison
Smart narrative
Eikon Therapeutics, Inc. Common Stock trades at $9.62. Our Smart Value Score of 20/100 indicates the stock is weak.
Frequently asked questions
What is Eikon Therapeutics, Inc. Common Stock's stock price?
Eikon Therapeutics, Inc. Common Stock (EIKN) trades at $9.62.
Is Eikon Therapeutics, Inc. Common Stock overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Eikon Therapeutics, Inc. Common Stock (EIKN)?
The analyst target price is $25.60, representing +166.3% upside from the current price of $9.62.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-125.00%
Beta—
50D MA$12.22
200D MA$12.42
Shares out0.05B
Float0.03B
Short ratio—
Avg volume0.4M
Performance
1 week-25.55%
1 month-10.91%
3 months—
YTD—
1 year—
3 years—
5 years—